News Archive 


GM

 

 

 

 

 

 

 

 

Program        

14-10-201614-10-2016Next General Assembly Meeting: Tuesday, March 11th 2008, 18h00.
Auditorium Kiekens, Universitair Ziekenhuis Brussel
Key note:
Essential haematology and toxicology in the therapeutic monitoring of clozapine and other psychoactive drugs
Dr Edgar P. Spencer, Medical Toxicology Unit, St Thomas’ Hospital, London

Full program

BLT GA 2007
Accreditation information

Organizer 4.191 UZ Gent
Lecturer Verstraete
Ratification No 4796.0189
Section 3
Title BLT Annual Meeting
Duration 2 hrs
Code CP 2.0

 


BLT Weekend: Echternach 29/09/2007

Drugs in discotheques - Self and social control: cultural relations and illicit drug use in the making

Clinical applications of molecular pharmaco-/toxicogenetics: current data and perspectives

Free Communications

GHB, identified by mass spectrometry as leading drug of abuse during rave-parties. Leonidas Banyihishako1, Vincent Di Fazio2, Roger Vanbinst2, Alain Berny1, André Renaux1, Daniel Malempré1, Bernadette Cuvelier3 and Pierre Wallemacq2. 1Hôpital St Joseph, Laboratoire de Biologie Clinique, Gilly; 2 Université Catholique de Louvain, Cliniques Universitaires St Luc, Department of Clinical Chemistry ; 3 Clinique Notre Dame, Service des Urgences, Charleroi, Belgium.

Can Pharmacokinetics of Amikacin Help to Predict Adequate Dosage Regimen of β-Lactams in ICU Patients with Severe Sepsis or Septic Shock? I. Delattre1, T. Dugernier2, H. Spapen3, P.F. Laterre1, F.S. Taccone4, B. Layeux4, X. Wittebolle1, D. De Backer4, J.L. Vincent4, F. Jacobs4 and P. Wallemacq1
1Université Catholique de Louvain, St-Luc Hospital, Brussels; 2St-Pierre Hospital, Ottignies; 3AZ-VUB, Brussels; 4Erasme Hospital, Brussels; Belgium

POPULATION PHARMACOKINETIC ANALYSIS AND BAYESIAN ESTIMATION OF MYCOPHAENOLIC ACID IN STABLE RENAL TRANSPLANTS TREATED SUCESSIVELY WITH CYCLOSPORINE AND SIROLIMUS CO-MEDICATION Musuamba TF, Rousseau A., Bosmans J, Senessael JJ, Verbeeck R, Wallemacq P

Penguin rookeries as point source of contamination with persistent organic pollutants. Laurence Roosens1, Nico Van Den Brink2, Martine Riddle4, Ronny Blust3, Hugo Neels1, Adrian Covaci1,3.1- Toxicological Centre, Department of Pharmaceutical Sciences, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium. 2- Alterra, Box 47, Wageningen UR, NL-6700 AA Wageningen, The Netherlands. 3- Laboratory of Ecophysiology, Biochemistry and Toxicology, Department of Biology, University of Antwerp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium. 4- Australian Antarctic Division, Channel Highway, Kingston, Tasmania, Australia